That is essential, because the method a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (black sea). And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're designed to do. This was a development almost no one discovered. However it's going to have extensive implications for treating illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment opportunities in this space, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff bezos). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps considerably before going greater - united arab emirates. I have actually been covering bitcoin for a long time now. Among the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were primarily informing readers. However that's not the huge concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. white house. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of fantastic private business on the verge of hitting the general public markets And I have actually been working on a new method for you to invest even prior to these companies go public.
This chance has actually been developing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to book your spot totally free.
Emma Walsh here, managing editor of the Journal. Routine Diary readers understand that tech isn't our usual beat (united states). And when it pertains to tech investing, we leave it to the professionals. Fortunately, we have numerous such specialists in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing professionals we understand (longtime readers). In truth, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the big image and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These patterns are experiencing rapid growth and creating amazing opportunities for financiers. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. genetic sequencing companies jeff brown. However regardless of what numerous readers might think, this is a pattern that's just getting started. Despite the fact that the COVID-19 pandemic interrupted supply chains last year, a remarkable 250 million 5G-enabled gadgets were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (biotech stocks). Losing 2 months of manufacturing and sales really impacts the number of 5G gadgets are offered in the fiscal year. When you think about all of that, selling 250 million systems is remarkable. More notably, the delays brought on by the pandemic created a lot of pent-up demand. And that demand is now going to be pressed into 2021. In truth, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - diplomatic relations. Which's not my only 5G forecast When I have actually spoken about 5G in the past, I've explained its three various stages.
In Phase 2, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Stage Three, 5G services begin to be offered (jeff brown stock market prediction). That's when we begin to see applications running on 5G networks. Consider things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage Three by this summertime. This begins something of a virtuous cycle: The majority of people do not actually care about the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open a suite of amazing applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The financial investment opportunities moving forward will be massive. Stepping far from 5G, the next crucial technology I predict in 2021 is CRISPR genetic editing. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR uses a similar concept but with our genetic code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For several years, CRISPR was primarily a niche technology that wasn't well understood. And during that time, there were actually just 3 business operating in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're treating diseases and seeing that this innovation just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing extraordinary returns. This whole industry is efficiently a greenfield chance.
There's space for many companies to exist in this area. jeff brown biotech stocks. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or three more genetic modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things taking place at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software can precisely predict the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is essential since the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error process. Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but a number of drug therapies produced using this innovation. This was among those advancements that almost nobody discovered. However it's going to have extensive implications for curing disease. And, naturally, there will be a lot of investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it drew back possibly considerably before going higher. I have actually been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin - toxic tech 5 tech darlings. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. But at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. genetic sequencer stock jeff brown. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date since February 2021, but we might not independently validate this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to pick winning innovation stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an outstanding perspective on the marketplace. He's always on the hunt for brand-new chances, and he shares a lot of his best choices in the Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he effectively forecasted a few of the most significant economic occasions of the past twenty years. Although he doesn't appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it right whenever, however Jeff Brown's precise forecasts have earned him legions of dedicated fans. That says a lot about his capability. The Near Future Report is released by Brownstone Research, a popular financial research study publisher. Brownstone Research study uses several research services with a large range of specializations - genetic sequencing companies jeff brown.
The business is likewise associated with Bonner & Partners, another well-respected research publisher - biotech stock. On its website, Brownstone says its mission is to offer retail financiers with professional-grade research study: "For too long, the very best financial investment research study has not been available to specific financiers. It has been generally booked for financial investment banks, hedge funds, private equity, and high-net-worth clients. exponential tech investor. The mission of Brownstone Research is to make that sort of exclusive research study readily available to any investors seeking to acquire an edge in the marketplaces. The objective is basic to provide distinct and rewarding financial investment research discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise acts as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you understand even a bit about the market, you know that he has a reputation as a King Midas of sorts. tech predictions. Whatever he touches turns to gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown believes S.A.V. united arab emirates. could be "the biggest trend of the 2020s, and he's not alone. Check out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying 2 advanced technologies: expert system and electric automobiles. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving cars and trucks ever. It's nothing except the automobile industry's Holy Grail. As you know, electric automobiles and self-driving automobile stocks have been huge this year, but the Wall Street device has actually approved hype without much tangible outcome. Regardless of a drastic boost in competitors over the previous few years, Brown still believes Musk has the best chance of putting it all together.
tech could be the magic string that connects it all together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transport. Essentially, this innovation would permit you to lease your automobile as an autonomous, self-driving taxi when you're not using it. You merely leave the automobile and press a button on an app that informs the cars and truck to "join the fleet." Next thing you know, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Best of all, you get to keep a hefty portion of the revenues. It sounds crazy, however it might be closed than you believe.